Logo image of SSA.CA

SPECTRA PRODS INC (SSA.CA) Stock Fundamental Analysis

TSX-V:SSA - TSX Venture Exchange - CA84757D2095 - Common Stock - Currency: CAD

0.2  0 (0%)

Fundamental Rating

5

Taking everything into account, SSA scores 5 out of 10 in our fundamental rating. SSA was compared to 5 industry peers in the Automobile Components industry. SSA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SSA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SSA was profitable.
SSA had a positive operating cash flow in the past year.
Each year in the past 5 years SSA has been profitable.
Each year in the past 5 years SSA had a positive operating cash flow.
SSA.CA Yearly Net Income VS EBIT VS OCF VS FCFSSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K

1.2 Ratios

SSA has a better Return On Assets (7.52%) than 100.00% of its industry peers.
With a decent Return On Equity value of 9.41%, SSA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
SSA has a Return On Invested Capital (6.95%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SSA is in line with the industry average of 7.01%.
Industry RankSector Rank
ROA 7.52%
ROE 9.41%
ROIC 6.95%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
SSA.CA Yearly ROA, ROE, ROICSSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

Looking at the Profit Margin, with a value of 10.25%, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SSA has declined.
The Operating Margin of SSA (11.05%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of SSA has declined.
Looking at the Gross Margin, with a value of 47.79%, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of SSA has declined.
Industry RankSector Rank
OM 11.05%
PM (TTM) 10.25%
GM 47.79%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
SSA.CA Yearly Profit, Operating, Gross MarginsSSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

10

2. Health

2.1 Basic Checks

SSA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SSA has less shares outstanding than it did 1 year ago.
SSA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SSA has an improved debt to assets ratio.
SSA.CA Yearly Shares OutstandingSSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SSA.CA Yearly Total Debt VS Total AssetsSSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

SSA has an Altman-Z score of 3.15. This indicates that SSA is financially healthy and has little risk of bankruptcy at the moment.
SSA has a Altman-Z score of 3.15. This is amongst the best in the industry. SSA outperforms 100.00% of its industry peers.
The Debt to FCF ratio of SSA is 0.64, which is an excellent value as it means it would take SSA, only 0.64 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SSA (0.64) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that SSA is not too dependend on debt financing.
SSA's Debt to Equity ratio of 0.07 is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.64
Altman-Z 3.15
ROIC/WACC0.84
WACC8.32%
SSA.CA Yearly LT Debt VS Equity VS FCFSSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K 1M -1M 1.5M

2.3 Liquidity

A Current Ratio of 6.42 indicates that SSA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 6.42, SSA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
SSA has a Quick Ratio of 5.62. This indicates that SSA is financially healthy and has no problem in meeting its short term obligations.
SSA has a better Quick ratio (5.62) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.42
Quick Ratio 5.62
SSA.CA Yearly Current Assets VS Current LiabilitesSSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

0

3. Growth

3.1 Past

The earnings per share for SSA have decreased strongly by -21.94% in the last year.
SSA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -27.10% yearly.
The Revenue for SSA has decreased by -14.01% in the past year. This is quite bad
The Revenue has been decreasing by -4.04% on average over the past years.
EPS 1Y (TTM)-21.94%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%51.85%
Revenue 1Y (TTM)-14.01%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%10.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSA.CA Yearly Revenue VS EstimatesSSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.00, the valuation of SSA can be described as rather expensive.
SSA's Price/Earnings ratio is rather expensive when compared to the industry. SSA is more expensive than 80.00% of the companies in the same industry.
SSA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.29.
Industry RankSector Rank
PE 20
Fwd PE N/A
SSA.CA Price Earnings VS Forward Price EarningsSSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

80.00% of the companies in the same industry are cheaper than SSA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SSA indicates a rather expensive valuation: SSA more expensive than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.65
EV/EBITDA 5.62
SSA.CA Per share dataSSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

The decent profitability rating of SSA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SSA!.
Industry RankSector Rank
Dividend Yield N/A

SPECTRA PRODS INC

TSX-V:SSA (7/16/2025, 7:00:00 PM)

0.2

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners26.6%
Inst Owner ChangeN/A
Ins Owners8.12%
Ins Owner ChangeN/A
Market Cap2.73M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20
Fwd PE N/A
P/S 1.6
P/FCF 8.65
P/OCF 8.65
P/B 1.47
P/tB 1.47
EV/EBITDA 5.62
EPS(TTM)0.01
EY5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY11.56%
OCF(TTM)0.02
OCFY11.56%
SpS0.12
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 9.41%
ROCE 9.46%
ROIC 6.95%
ROICexc 28.86%
ROICexgc 28.86%
OM 11.05%
PM (TTM) 10.25%
GM 47.79%
FCFM 18.51%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
ROICexc(3y)25.04%
ROICexc(5y)32.76%
ROICexgc(3y)25.04%
ROICexgc(5y)32.76%
ROCE(3y)11.57%
ROCE(5y)16.41%
ROICexcg growth 3Y-19.46%
ROICexcg growth 5Y-7.33%
ROICexc growth 3Y-19.46%
ROICexc growth 5Y-7.33%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 0.64
Debt/EBITDA 0.54
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 26.15
Cash Conversion 127.49%
Profit Quality 180.54%
Current Ratio 6.42
Quick Ratio 5.62
Altman-Z 3.15
F-Score6
WACC8.32%
ROIC/WACC0.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)225.95%
Profit Quality(5y)198%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.94%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%51.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.01%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%10.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.79%
EBIT growth 3Y-26.38%
EBIT growth 5Y-17.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.74%
FCF growth 3Y-7.27%
FCF growth 5Y-9.48%
OCF growth 1Y19.74%
OCF growth 3Y-7.27%
OCF growth 5Y-9.92%